Atrial natriuretic peptide increases urinary albumin excretion in men with type 1 diabetes mellitus and established microalbuminuria

Diabetic Medicine

Volumn 15, Issue 8, 1998, Pages 678-682

  Prasad, N ^a   Clarkson, P B M ^a   MacDonald, T M ^a   Ryan, M ^a   Struthers, A D ^a   Thompson, C J ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Atrial natriuretic peptide; Diabetes mellitus; Microalbuminuria

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; GLUCOSE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROALBUMINURIA; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALBUMINURIA; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIURESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSIONS, INTRAVENOUS; MALE;

EID: 0031817148     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199808)15:8<678::AID-DIA639>3.0.CO;2-K     Document Type: Article

References (26)

1. Bell GM, Bernstein RK, Laragh JH, Atlas SA, James GD, Pecker MS, Sealey JE. Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 1989; 77: 177-182.
2. Fioretto P, Sambataro M, Cipollina MR, Giorato C, Carraro AA, Opocher G, et al. Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes 1992; 41: 936-945.
3. Jungmann E, Graeber S, Scherberich J, Usadel KH. The role of human atrial natriuretic peptide on the pathogenesis of nephropathy in patients with type 1 diabetes mellitus. Medizinische Klinik 1992; 87: 622-625.
4. Firth R, Gafney M, Skelly R, Deegan P, Dowsett D. Is atrial natriuretic peptide (ANP) associated with hyperfiltration in diabetics (Abstract)? Diabetologia 1993; 36 suppl 1: A217.
5. Ferri C, De Mattia G, Piccoli A, Santucci A, Laurenti O, Balsano F, Bellini C. Atrial natriuretic factor in hypertensive and normotensive diabetic patients. Diabetes Care 1994; 17: 195-200.
6. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am J Physiol 1994; 266: R442-R450.
7. Sawicki P, Heinemann L, Rave K, Berger M. Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy. Zeitschrift Fur Kardiologie 1988; 77 suppl: 111-113.
8. McKnight J, Roberts G, Sheridan B, Bell PM, Atkinson AB. Basal and stimulated plasma atrial natriuretic factor in patients with Type 1 diabetes, with and without nephropathy. Diabetic Med 1991; 8: 765-769.
9. McMurray J, Seidelin PH, Howey JEA, Balfour DJ, Struthers AD. The effect of atrial natriuretic factor on urinary albumin and β2-microglobulin excretion in man. J Hyp 1988; 6: 783-786.
10. Zietse R, Schalekamp MA. Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome. Kidney Int 1988; 34: 717-724.
11. Hirata Y, Ishii M, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, et al. Differential effects of atrial natriuretic peptide and dopamine on urinary protein excretion in chronic glomerulonephritis. Clin Sci 1991; 80: 131-136.
12. Shinoda T, ishihara M, Kurimoto F, Aizawa T, Hiramatsu K, Shinota T, et al. Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin dependent diabetes mellitus. Clin Neph 1990; 34: 202-207.
13. Jungmann E, Seel K, Hotmann E, Scheuermann EH, Schoffling K. Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycaemic patients with diabetes mellitus. Klinische Wochenschfift 1989; 67: 1174-1181.
14. Fukui K, Hirata Y, Kimura K, Sugimoto T, Matsuoka H, Ishii M. The effects of atrial natriuretic peptide on urinary protein excretion in patients with renal parenchymal disease and those with diabetes mellitus. Nippon linzo Gakkai Shi 1990; 32: 199-205.
15. Zietse R, Derkx FH, Weimar W, Schalekamp MA. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J. Am Soc Nephrol 1995; 5: 2057-2066.
16. Clark BA, Sclater A, Epstein FH, Elahi D. Effects of glucose, insulin and hypertonicity on atrial natriuretic peptide levels in man. Metabolism 1993; 42: 224-228.
17. Todd ME, Hebden RA, Gowen B, Tang C, McNeill JH. Atrial structure and plasma ANF levels in rats with chronic diabetes mellitus. Diabetes 1990; 39: 483-489.
18. Perico N, Benigni A, Gabanelli M, Piccinelli A, Rog M, De Riva C, Remuzzi G. Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 1992; 41: 533-538.
19. Hirata Y, Suzuki Y, Hayakawa H, Suzuki E, Kimura K, Goto A, Kangawa K, Matsuo H, Omata M. Participation of endogenous atrial natriuretic peptide in the regulation of urinary protein excretion in experimental diabetic rats. Clin Sci 1995; 8: 413-419.
20. Sakamato K, Kikkawa R, Haneda M, Shigeta Y. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist. Diabetologia 1995; 38: 536-542.
21. Ortola FV, Ballerman BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats; potential mediator of hyperfiltrafion. J Clin Invest 1987; 80: 670-674.
22. Jaffa AA, Rust PF, Mayfield RK. Kinin, a mediator of diabetes-induced glomerular hyperfiltation. Diabetes 1995; 44: 156-160.
23. Bank N, Aynedjian HS. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993; 43: 1306-1312.
24. Viberti GC, Mogensen CE, Keen H, Jacobsen FK, Jarrett RJ, Christensen CK. Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest 1982; 42: 147-151.
25. Wiegmann TB, Chonko AM, Herron K, MacDougall ML, Moore WV. The effect of water loading on albumin excretion in type 1 diabetes mellitus. J Diabetic Complic 1989; 3: 187-189.
26. The Diabetic Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.